| [Charts] Roasting Shorts and the Fake-Brain Boom - Heavily shorted stocks (just like GameStop) are surging everywhere
- But that does not mean you should jump into garbage stocks like GME
- The biggest winner in the coming takeover offers will be…
Recommended Link
 Lou Basenese
Editor and Founder, Trend Trader Daily
Dear Wall Street Daily Reader, If you think the GameStop Corp. (GME) saga only involves a small handful of heavily-shorted stocks, think again… As Bespoke Investment Group noted last week, pretty much every heavily-shorted stock in the Russell 3000 with a nose-bleed valuation is surging. Take a look: 
For any of you who own stocks that are heavily shorted and super expensive, expect to see your profits keep climbing. But please don’t mistake that statement as an endorsement to own garbage stocks like GameStop. Recommended Link
Remember This? 
Another major crisis is on the horizon that could make things even WORSE in 2021. | |
To the contrary, as I told you earlier, you should be adding them to your “Stocks to Short Watchlist,” not your long investment portfolio. But I know what some of you will ask next: “So Lou, if we shouldn’t be focusing on buying or short-selling those stocks right now, where should we be investing?” Glad you asked: In short, I recommend you bet on “fake brains.” Let me explain… As Business Insider Intelligence reports, “AI [Artificial Intelligence] is the most disruptive technology in pharma.” Preach it! You see, by harnessing the power of AI, drug companies can slash the time and cost associated with drug development — and therefore, they can save more lives sooner. And of course, mint a lot of profits while they’re doing so. To be clear, I’m not putting profits over people here… I’m just keeping focused on what you come here to read about. And that’s actionable investment ideas. With that in mind, I’m convinced a big opportunity is brewing for everyday investors in small-cap AI drug discovery platforms. Especially since, as you can see in the chart below, a disparity exists among big pharma companies and their commitment and investment in AI. 
Simply put, many mega-cap pharma companies need to play catch up in a big way. And the fastest way to do so is to innovate through — you guessed it — acquiring promising AI startups. Now, I’ve made no bones about my bullishness for biotech investments in 2021. That’s why biotech is where I’m allocating the largest percentage of my personal portfolio. If you’re diving in on your own, here’s what I recommend… Find small-cap companies with AI-based drug discovery platforms. I’m convinced these small companies will be on the receiving end of big takeover offers in 2021. Of course, there’s much more to identifying winning biotechs than just small caps with AI-based drug discovery platforms… In fact I have a whole 7-step system for identifying the biggest biotech breakouts. We’ll talk more about it soon… Ahead of the tape, 
Lou Basenese
Editor and Founder, Trend Trader Daily Louis Basenese is a professional investor, and one of the country’s leading technology analysts. He’s spent the past 20 years analyzing emerging technologies, and developing a proven methodology to consistently profit from them. Lou began his investment career at Morgan Stanley, where he was eventually tasked with directing over $1.5 billion in capital. Based on his proven track record as a financial analyst and investor, Lou became a television commentator on Fox Business and CNBC, and a market expert in the pages of The Wall Street Journal and Business Insider. But ultimately, Lou found he preferred helping Main Street investors like you. By providing ordinary investors with extraordinary research, he discovered that he can help his readers change their financial futures, and change their lives for the better. And that explains why he recently launched Trend Trader Daily. With this new service, Lou can share his research with you on groundbreaking new technologies and emerging sectors — well before he shares this information with the general public on TV, the internet, or anywhere else. Recommended Link
Biden... Boom? 
If you're rolling the dice on a Biden boom, pay attention... Because new research has come to light. A former advisor to the CIA... and the Pentagon... Has just recently revealed -- on camera -- proof that Joe Biden and Kamala Harris are not equipped for reversing this crisis. Frankly, nobody in Washington is. Because, says this ex-insider, every last one of them is too late. In the fallout ahead, most stocks will collapse... the dollar could fail... But there's one strategy that could rebound, as high as 300% or higher over the next five years. | |
| 
© 2021 Paradigm Press, LLC. 808 Saint Paul Street, Baltimore MD 21202. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. 
No comments:
Post a Comment